Roger D. Tung
2018
In 2018, Roger D. Tung earned a total compensation of $4.6M as President and Chief Executive Officer at Concert Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,421 |
|---|---|
| Option Awards | $3,761,860 |
| Salary | $535,511 |
| Other | $10,056 |
| Total | $4,607,848 |
Tung received $3.8M in option awards, accounting for 82% of the total pay in 2018.
Tung also received $300.4K in non-equity incentive plan, $535.5K in salary and $10.1K in other compensation.
Rankings
In 2018, Roger D. Tung's compensation ranked 2,265th out of 14,244 executives tracked by ExecPay. In other words, Tung earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,265 out of 14,244 | 84th |
Division Manufacturing | 828 out of 5,765 | 86th |
Major group Chemicals And Allied Products | 278 out of 2,128 | 87th |
Industry group Drugs | 224 out of 1,817 | 88th |
Industry Pharmaceutical Preparations | 174 out of 1,391 | 88th |
Source: SEC filing on April 29, 2019.
Tung's colleagues
We found two more compensation records of executives who worked with Roger D. Tung at Concert Pharmaceuticals in 2018.
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019